Context Therapeutics and Symbotic Miss Quarterly Earnings Expectations

Context Therapeutics (NASDAQ:CNTX) reported earnings of a $(0.15) loss per share for the quarter, missing analysts' consensus of $(0.10) by $(0.05). The stock rose $0.07 to $0.69 on the day, with about 2.32 million shares traded. Analysts adjusted ratings, with Wall Street downgrading the stock to a "strong sell" and other firms lowering price targets.

Symbotic (NASDAQ:SYM) posted earnings of $0.09 per share, falling short of the $0.13 consensus by $0.04. Revenue reached $720.84 million, slightly above the $715.03 million estimate and up 21.7% year‑over‑year. The company recorded a negative net margin of 0.20% and a negative return on equity of 0.68%, while its backlog remained at $22.5 billion. Shares traded down $0.94 to $46.52.